BECN1 and neoplasm: This effect was restored by blocking either BECLIN 1 or ATG5 with siRNA and resulted in the decrease of pSTAT3 and rehabilitation of hypoxic tumor cell susceptibility to CTL-mediated cytotoxicity [174].